Loading...

Press Releases


C-Path and MitoAction Announce Data Sharing Agreement to Support Treatment Development in Mitochondrial Disease

TUCSON, Ariz., June 7, 2022 — Critical Path Institute (C-Path) and MitoAction today announced a joint collaboration to incorporate patient data for rare Read More


TK2d Patient Voices Elevated at FDA

FOR RELEASE FRIDAY, FEB. 4 AT 11:30AM

Monthly Expert Series

Gain knowledge from our guest speakers on topics important to the mitochondrial disease community.